Westphal, F; Girreser, U; Waldmüller, D. Analytical characterization of four new ortho-methoxybenzylated amphetamine-type designer drugs Drug Test. Anal., 1 Sep 2016, 8 (9), 910-919. 2.2 MB. https://doi.org/10.1002/dta.1889 #1 MS,NMR,IR
EMCDDA. New drugs in Europe, 2014, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2015. 879 kB.
Caspar, AT; Meyer, MR; Westphal, F; Weber, AA; Maurer, HH. Nano liquid chromatography-high-resolution mass spectrometry for the identification of metabolites of the two new psychoactive substances N-(ortho-methoxybenzyl)-3,4-dimethoxyamphetamine and N-(ortho-methoxybenzyl)-4-methylmethamphetamine Talanta, 1 Oct 2018, 188, 111–123. 1.7 MB. https://doi.org/10.1016/j.talanta.2018.05.064 #D1; 3,4-DMA-NBOMe LC,MS
25D-NBOMe · 2C-D-NBOMe · N-(2-Methoxybenzyl)-4-methyl-2,5-dimethoxyphenethylamine
25E-NBOH · 2C-E-NBOH · N-(2-Hydroxybenzyl)-4-ethyl-2,5-dimethoxyphenethylamine
2,4-DMA-NBOMe · N-(2-Methoxybenzyl)-2,4-dimethoxyamphetamine
25D-NB3OMe · N-(3-Methoxybenzyl)-4-methyl-2,5-dimethoxyphenethylamine
25D-NB4OMe · N-(4-Methoxybenzyl)-4-methyl-2,5-dimethoxyphenethylamine
2,5-Dimethoxy-4-(3-methoxybenzyl)amphetamine · DO3MeOBz
2,5-Dimethoxy-4-(4-methoxybenzyl)amphetamine · DO4MeOBz
2,5-Dimethoxy-4-(3-methoxybenzyl)amphetamine · DO2MeOBz